Papillary thyroid carcinoma with pulmonary metastasis is relatively uncommon which can be treated with radioactive iodine therapy. Here, our experiences with two cases of papillary thyroid carcinoma with pulmonary metastases in young patients are discussed.
INTRODUCTION

Thyroid cancers are the most common endocrine malignant tumors. Papillary thyroid carcinoma (PTC)
is the most frequent type of differentiated thyroid carcinoma (DTC) with a ratio of 80% (1, 2) . PTC commonly metastasizes to regional lymph nodes.
However, distant metastasis may occur in 5% patients-lung and bones being the most common sites for distant metastases (3) . Though the prognosis of the disease is excellent following radioiodine ablation/therapy, 10-year survival is approximately 25-40% in case of distant metastasis (4, 5).
Here we reported our experience with two cases of PTC having pulmonary metastasis.
CASE REPORT -I
A 23-year old unmarried female patient with papillary thyroid carcinoma (PTC) was referred to our institute in He was clinically normal. He was followed up regularly and DxWBS done after one year which revealed no abnormal uptake in thyroid bed as well as in lung field or any other part of the body.
DISCUSSION
Primary thyroid cancers are histologically divided in four groups: i) Well differentiated epithelial cancers, ii) Poorly differentiated epithelial thyroid cancer iii). Medullay thyroid cancer and iv) Rare thyroid tumors (lymphoma, sarcoma, squamous cell carcinoma etc). Of these differentiated thyroid carcinoma (DTC) papillary and follicular constitute the largest part with a rate of over 90% (6) . Papillary thyroid cancer (PTC) is the most common type of differentiated thyroid cancers (3).
Treatment of differentiated thyroid carcinoma includes total/near total thyroidectomy followed by radioactive iodine ablation and TSH suppression by Thyroxine. In case of PTC the 10-year survival rate is 93% following total thyroidectomy and radioiodine ablation. It is one of the best treatable cancers. Young patients with small tumors without invasion have better prognosis (7) . A thyroid carcinoma may be associated with a high TSH stimulation. A study conducted with rats reported the presence of long term elevated TSH levels resulting in a thyroid carcinoma with lung metastasis (8) . TSH suppression is mandatory for good prognosis as it inhibits growth of cancer cells (9) . First patient reported here, developed lung metastases after 5 years and during that period she was irregular in thyroxine intake and had high TSH level at the time of detection of lung metastases. About 10 to 15% of patients with papillary thyroid carcinoma develop distant metastases-80% of which occur in lungs (10) . Two distinct type of metastasis occur in lungs parenchyma -miliary metastasis and multiple nodules (11) .
Pulmonary metastases have good prognosis with I-131 when they are undetectable in chest X-ray (12).
One of our reported patients showed multiple nodules in both lung fields. The other had solitary pulmonary nodule and both of them had positive chest X-ray.
Both of them showed good response to radioiodine ablation and became disease free after radioiodine therapy probably due to early detection and treatment.
CONCLUSION
Metastatic PTC is an uncommon condition that generally has a relatively good prognosis when diagnosed and treated easily. Adequate TSH suppression and regular follow up are mandatory for DTC patients following radioactive iodine ablation to prevent recurrence.
